Alcohol Recovery Drug ‘More Effective’ Among Patients with Genetic Variant

November 7, 2014

(Medical News Today) – Genetic markers have been identified that could help identify alcohol-dependent patients for whom the drug acamprosate may be beneficial. The researchers behind the study, from the Mayo Clinic in Rochester, MN – publish their findings in the journal Translational Psychiatry. Acamprosate is commonly prescribed as part of alcohol recovery treatment. The drug works by restoring the chemical imbalances in the brain that occur when someone who is alcohol dependent quits drinking.